Bio-Path Holdings, Inc. (BPTH)
OTCMKTS
· Delayed Price · Currency is USD
0.1699
+0.0073 (4.49%)
Jul 11, 2025, 11:57 AM EDT
Bio-Path Holdings Employees
Bio-Path Holdings had 10 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
10
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$958,900
Market Cap
1.35M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo, Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 374 |
| American Oncology Network | 1,914 |
| CytoDyn | 9 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
Bio-Path Holdings News
- 5 weeks ago - Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 25 - Newsfile Corp
- 5 weeks ago - Bio-Path Holdings Provides Clinical and Operational Update - GlobeNewsWire
- 7 weeks ago - Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025 - GlobeNewsWire
- 2 months ago - Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients - GlobeNewsWire
- 3 months ago - Bio-Path GAAP EPS of -$4.12 - Seeking Alpha
- 3 months ago - Bio-Path Holdings Reports Full Year 2024 Financial Results - GlobeNewsWire
- 4 months ago - Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients - GlobeNewsWire
- 5 months ago - ARMISTICE CAPITAL, LLC Acquires Significant Stake in Bio-Path Holdings Inc - GuruFocus